This article has Open Peer Review reports available.
A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy
© Daniels-Wells et al.; licensee BioMed Central Ltd. 2013
Received: 5 June 2012
Accepted: 6 March 2013
Published: 17 April 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|5 Jun 2012||Submitted||Original manuscript|
|7 Jun 2012||Author responded||Author comments - Tracy Daniels-Wells|
|Resubmission - Version 2|
|7 Jun 2012||Submitted||Manuscript version 2|
|10 Sep 2012||Reviewed||Reviewer Report - Dev Karan|
|8 Oct 2012||Reviewed||Reviewer Report - Francesco Novelli|
|12 Oct 2012||Reviewed||Reviewer Report - Mirella Giovarelli|
|14 Oct 2012||Reviewed||Reviewer Report - Myron Arlen|
|17 Dec 2012||Author responded||Author comments - Tracy Daniels-Wells|
|Resubmission - Version 3|
|17 Dec 2012||Submitted||Manuscript version 3|
|6 Feb 2013||Reviewed||Reviewer Report - Francesco Novelli|
|12 Feb 2013||Reviewed||Reviewer Report - Mirella Giovarelli|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|6 Mar 2013||Editorially accepted|
|17 Apr 2013||Article published||10.1186/1471-2407-13-195|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.